Product Information
TERIFLUNOMIDE 14 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.7487 per EA under NDC 16729040010. Its NADAC has been published 77 times since Sep 20, 2023.
The High Outlier badge above means this manufacturer's average price in the Teriflunomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
14 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729040010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TERIFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209690On Market Since
3/13/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIFLUNOMIDE 14 MG TABLET has been published 77 times since Sep 20, 2023, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7487 per EA |
|---|---|
| All-time high | $0.9109 (Oct 11, 2023) |
| All-time low | $0.3426 (Jul 17, 2024) |
| Median price | $0.6934 |
| Average price | $0.7029 |
| Largest weekly change | +63.1% (Aug 21, 2024) |
| Weeks tracked | 77 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERIFLUNOMIDE 14 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 14 MG TABLET, manufactured by Accord Healthcare Inc., is $0.7487 per EA (NDC 16729040010), effective Mar 5, 2025.
How has the price of TERIFLUNOMIDE 14 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERIFLUNOMIDE 14 MG TABLET has declined 17.8%. It has been tracked across 77 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 14 MG TABLET?
Since Sep 20, 2023, the NADAC for TERIFLUNOMIDE 14 MG TABLET has ranged from a low of $0.3426 (Jul 17, 2024) to a high of $0.9109 (Oct 11, 2023), with a median of $0.6934 per EA.
Are there cheaper alternatives to TERIFLUNOMIDE 14 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TERIFLUNOMIDE 14 MG TABLET, is $0.3692 per EA — about 51% below TERIFLUNOMIDE 14 MG TABLET.
Who manufactures TERIFLUNOMIDE 14 MG TABLET?
TERIFLUNOMIDE 14 MG TABLET (NDC 16729040010) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification